Bristol-Myers Squibb Co (BSP:BMYB34) E10: R$8.45 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:BMYB34 Bristol-Myers Squibb Co BSP:BMYB34
71 GF Score
Price R$294.81
GF Value R$275.11
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Bristol-Myers Squibb Co E10?

Bristol-Myers Squibb Co BSP:BMYB34 -2.90% 71 E10 is R$8.45 as of Mar. 2026. GuruFocus rates BSP:BMYB34 with a GF Score™ of 71/100 and a GF Value™ of R$275.11 (Fairly Valued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Bristol-Myers Squibb Co's adjusted earnings per share data for the three months ended in Mar. 2026 was R$6.851. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is R$8.45 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Bristol-Myers Squibb Co's average E10 Growth Rate was 19.40% per year. During the past 3 years, the average E10 Growth Rate was -1.20% per year. During the past 5 years, the average E10 Growth Rate was 3.20% per year. During the past 10 years, the average E10 Growth Rate was -3.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Bristol-Myers Squibb Co was 14.10% per year. The lowest was -16.40% per year. And the median was 1.90% per year.

As of today (2026-07-15), Bristol-Myers Squibb Co's current stock price is R$294.81. Bristol-Myers Squibb Co's E10 for the quarter that ended in Mar. 2026 was R$8.45. Bristol-Myers Squibb Co's Shiller PE Ratio of today is 34.89.

During the past 13 years, the highest Shiller PE Ratio of Bristol-Myers Squibb Co was 54.46. The lowest was 18.28. And the median was 33.60.


Bristol-Myers Squibb Co  (BSP:BMYB34) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Bristol-Myers Squibb Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=294.81/8.45
=34.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Bristol-Myers Squibb Co was 54.46. The lowest was 18.28. And the median was 33.60.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Bristol-Myers Squibb Co E10 Related Terms


Bristol-Myers Squibb Co E10 Historical Data

* Premium members only.

The historical data trend for Bristol-Myers Squibb Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bristol-Myers Squibb Co E10 Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.94 8.77 9.25 8.55 8.90

Bristol-Myers Squibb Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.95 8.09 8.21 8.90 8.45

BSP:BMYB34 vs PFE, GILD, AMGN: E10 Comparison

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Shiller PE Ratio falls into.


BSP:BMYB34
71GF Score
Bristol-Myers Squibb Co BSP:BMYB34
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bristol-Myers Squibb Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bristol-Myers Squibb Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=6.851/330.2130*330.2130
=6.851

Current CPI (Mar. 2026) = 330.2130.

Bristol-Myers Squibb Co Quarterly Data

per share eps CPI Adj_EPS
201606 2.362 241.018 3.236
201609 2.342 241.428 3.203
201612 1.778 241.432 2.432
201703 2.940 243.801 3.982
201706 1.845 244.955 2.487
201709 1.598 246.819 2.138
201712 -4.646 246.524 -6.223
201803 2.984 249.554 3.948
201806 0.867 251.989 1.136
201809 4.766 252.439 6.234
201812 2.835 251.233 3.726
201903 3.994 254.202 5.188
201906 3.354 256.143 4.324
201909 3.419 256.759 4.397
201912 -2.257 256.974 -2.900
202003 -1.661 258.115 -2.125
202006 -0.208 257.797 -0.266
202009 4.428 260.280 5.618
202012 -22.894 260.474 -29.024
202103 5.015 264.877 6.252
202106 2.363 271.696 2.872
202109 3.643 274.310 4.385
202112 6.051 278.802 7.167
202203 2.936 287.504 3.372
202206 3.331 296.311 3.712
202209 3.933 296.808 4.376
202212 4.983 296.797 5.544
202303 5.573 301.836 6.097
202306 4.805 305.109 5.200
202309 4.593 307.789 4.928
202312 4.263 306.746 4.589
202403 -29.331 312.332 -31.010
202406 4.470 314.175 4.698
202409 3.323 315.301 3.480
202412 0.244 315.605 0.255
202503 6.910 319.799 7.135
202506 3.549 322.561 3.633
202509 5.792 324.800 5.889
202512 2.892 324.054 2.947
202603 6.851 330.213 6.851

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of R$8.45 mean?
Bristol-Myers Squibb Co (BSP:BMYB34) has a E10 of R$8.45 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Bristol-Myers Squibb Co and its competitors.
Is Bristol-Myers Squibb Co's E10 too high?
Bristol-Myers Squibb Co's current E10 is R$8.45. Overall, Bristol-Myers Squibb Co has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bristol-Myers Squibb Co's E10 compare to PFE and GILD?
Bristol-Myers Squibb Co's E10 of R$8.45 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Bristol-Myers Squibb Co and its competitors. Bristol-Myers Squibb Co's current E10 is R$8.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bristol-Myers Squibb Co stock overvalued right now?
Based on GuruFocus' analysis, Bristol-Myers Squibb Co (BSP:BMYB34) is currently considered Fairly Valued. The stock's GF Value™ is R$275.11, compared to a current price of R$294.81 — trading 7.2% above its estimated fair value. The current E10 is R$8.45. Bristol-Myers Squibb Co's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Bristol-Myers Squibb Co (BSP:BMYB34), the current E10 is R$8.45 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bristol-Myers Squibb Co (BSP:BMYB34) Overvalued in 2026?

Based on GuruFocus' analysis, Bristol-Myers Squibb Co stock appears to be overvalued. The current stock price of R$294.81 is trading 7.2% above its estimated GF Value™ of R$275.11. GuruFocus considers Bristol-Myers Squibb Co to be Fairly Valued.

Key valuation signals for BSP:BMYB34:

  • E10: R$8.45
  • GF Value™: R$275.11 vs. price of R$294.81 (7.2% above fair value)
  • GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the BSP:BMYB34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bristol-Myers Squibb Co Business Description

Address Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
71GF Score

Get the complete analysis for BSP:BMYB34

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$294.81
Price
R$275.11
GF Value